Pharmacyclics
Pharmacyclics, an AbbVie company based in the Bay Area, California, is dedicated to helping people impacted by cancer and immune-mediated diseases by developing safe and effective treatments. Their mission is to help patients and their families rediscover the Magic of Normal, where disease no longer defines everyday life.
Industries
Nr. of Employees
large (251-1000)
Patents
Mutations associated with resistance to inhibitors of Bruton's Tyrosine Kinase (BTK)
US-10954567-B2
View DetailsSalts of 3-[(dimethylamino)methyl]-N-{2-[4-(hydroxycarbamoyl) phenoxy]ethyli-1-benzofuran-2-carboxamide, related crystalline forms, method for preparing the same and pharmaceutical compositions containing the same
US-10898461-B2
View Details
Mutations associated with resistance to inhibitors of Bruton's Tyrosine Kinase (BTK)
US-10954567-B2
View DetailsSalts of 3-[(dimethylamino)methyl]-N-{2-[4-(hydroxycarbamoyl) phenoxy]ethyli-1-benzofuran-2-carboxamide, related crystalline forms, method for preparing the same and pharmaceutical compositions containing the same
US-10898461-B2
View DetailsProducts
Investigator-Initiated Studies and Collaborative Research
Supports clinicians and researchers investigating ways to advance the care of people with serious illness.
Grants
Provides resources to medical and scientific communities working together to advance the care of patients with cancer.
Patient Support Program
Designed to help patients by providing one-on-one support and treatment-related resources.
Medical Information
Provides balanced, scientific, and evidence-based answers to unsolicited medical questions for healthcare professionals.
IMBRUVICA
IMBRUVICA (ibrutinib) is a prescription medicine used to treat adults with certain B-cell malignancies and chronic graft versus host disease.
Investigator-Initiated Studies and Collaborative Research
Supports clinicians and researchers investigating ways to advance the care of people with serious illness.
Grants
Provides resources to medical and scientific communities working together to advance the care of patients with cancer.
Patient Support Program
Designed to help patients by providing one-on-one support and treatment-related resources.
Medical Information
Provides balanced, scientific, and evidence-based answers to unsolicited medical questions for healthcare professionals.
IMBRUVICA
IMBRUVICA (ibrutinib) is a prescription medicine used to treat adults with certain B-cell malignancies and chronic graft versus host disease.
Expertise Areas
- Oncology drug development
- Immunology and immune-mediated disease therapeutics
- Therapeutic discovery through clinical development
Key Technologies
- Therapeutic development platforms
- Clinical development methodologies